Evidence map›Paper›PMID 25093114›Full record

ArticleActa naturae2014

Analysis of the placental tissue transcriptome of normal and preeclampsia complicated pregnancies.

E A Trifonova, T V Gabidulina, N I Ershov, V N Serebrova, A Yu Vorozhishcheva, V A Stepanov

Open access · bronzeAbstract read
In one paragraph

Article in Acta naturae, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Profiling the cytotoxic effects of naled and other pesticides in primary human placental cytotrophoblasts.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.Progress in molecular biology and translational science · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

E A TrifonovaResearch Institute of Medical Genetics, Siberian Branch, Russian Academy of Medical Sciences, Nab. Ushayky 10, 634050, Tomsk, Russia ; Tomsk State University, Lenina Avenue, 36, 634050, Tomsk, Russia.
T V GabidulinaSiberian State Medical University, Ministry of Health of the Russian Federation, Moskovsky Trakt, 2, 634050, Tomsk, Russia.
N I ErshovInstitute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, Prosp. Lavrentieva 10, 630090, Novosibirsk, Russia.
V N SerebrovaResearch Institute of Medical Genetics, Siberian Branch, Russian Academy of Medical Sciences, Nab. Ushayky 10, 634050, Tomsk, Russia.
A Yu VorozhishchevaCity Clinical Hospital № 1, Ul. Khitarova, 32, 654000, Novokuznetsk, Russia.
V A StepanovResearch Institute of Medical Genetics, Siberian Branch, Russian Academy of Medical Sciences, Nab. Ushayky 10, 634050, Tomsk, Russia ; Tomsk State University, Lenina Avenue, 36, 634050, Tomsk, Russia.
Research Institute of Medical Genetics of Russian Academy of Medical Sciences · RUCity Clinical Hospital · RUInstitute of Cytology and Genetics · RUMinistry of Health of the Russian Federation · RUNational Research Tomsk State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preeclampsia is one of the most severe gestational complications which is one of the leading causes of maternal and perinatal morbidity and mortality. A growth in the incidence of severe and combined forms of the pathology has been observed in recent years. According to modern concepts, inadequate cytotrophoblast invasion into the spiral arteries of the uterus and development of the ischemia-reperfusion syndrome in the placental tissue play the leading role in the development of preeclampsia, which is characterized by multipleorgan failure. In this regard, our work was aimed at studying the patterns of placental tissue transcriptome that are specific to females with PE and with physiological pregnancy, as well as identifying the potential promising biomarkers and molecular mechanisms of this pathology. We have identified 63 genes whose expression proved to differ significantly in the placental tissue of females with PE and with physiological pregnancy. A cluster of differentially expressed genes (DEG) whose expression level is increased in patients with preeclampsia includes not only the known candidate genes that have been identified in many other genome-wide studies (e.g., LEP, BHLHB2, SIGLEC6, RDH13, BCL6), but also new genes (ANKRD37, SYDE1, CYBA, ITGB2, etc.), which can be considered as new biological markers of preeclampsia and are of further interest. The results of a functional annotation of DEG show that the development of preeclampsia may be related to a stress response, immune processes, the regulation of cell-cell interactions, intracellular signaling cascades, etc. In addition, the features of the differential gene expression depending on preeclampsia severity were revealed. We have found evidence of the important role of the molecular mechanisms responsible for the failure of immunological tolerance and initiation of the pro-inflammatory cascade in the development of severe preeclampsia. The results obtained elaborate the concept of the pathophysiology of preeclampsia and contain the information necessary to work out measures for targeted therapy of this disease. ;

Indexed as

gene expressiongenome-wide analysismicroarraysplacentapreeclampsiatranscriptome

Identifiers

PMID25093114
PMCPMC4115229
OpenAlexW2162325336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.